Natco Pharma Ltd. Financials

NSE BSE

15:59 Jul 18

Natco Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

1035.10

+2.35 (+0.23%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

1035.10

+2.35 (+0.23%)
15:59 Jul 18

Quality

79/100
High Financial Strength

Valuation

56/100
Affordable Valuation

Technical

52/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Net Sales	2052.1	1944.8	2707.1	3998.8	4429.5
Operating Expenses +	1445.9	1681.3	1771.5	2247.4	2233.5
Raw Material	559.5	577.7	651	673.9	702.3
Increase Decrease in Cost	-48.1	-16.8	-23.7	42.7	-12.5
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	414.9	444.8	486.7	525	594.5
Miscellaneous Expenses	892.8	792.6	1008.9	1308.6	1281.4
Operating Profit	606.2	263.5	935.6	1751.4	2196
Other Income	103.6	99	104.6	128.1	354.5
Depreciation	116.9	142.6	163.8	186.8	235.2
Interest	13.3	17.7	14.5	19.2	23.9
Profit before tax and exceptio..	579.6	202.2	861.9	1673.5	2291.4
Exceptional Items	0	0	0	0	0
PBT	579.6	202.2	861.9	1673.5	2291.4
Provision for Taxation	137.2	32.2	146.6	285.2	408
Net Profit	442.4	170	715.3	1388.3	1883.4
NET Profit after MI	440.9	170	715.3	1388.3	1885.4
EPS	24.16	9.32	39.18	77.34	105.26
Operating Profit Margin (%)	29.54	13.55	34.56	43.8	49.58
Net Profit Margin (%)	21.49	8.74	26.42	34.72	42.56

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	49.60	49.60	49.60	49.60	49.70
FII	15.50	17.50	17.90	17.50	17.40
MF	2.10	1.80	1.90	2.40	2.70
Others	3.70	3.80	3.70	4.40	5.20

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: